Amgen presented new compelling data from the Phase 3 FOURIER open label extension (OLE) studies of Repatha (evolocumab) in adults with atherosclerotic cardiovascular disease...
Recently, Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. and Shanghai KangaBio Co., Ltd. (KangaBio) have reached an antibody drug licensing agreement, regarding a proprietary monoclonal antibody...
Bristol Myers Squibb in collaboration with Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen), announced results from the...
Athos Therapeutics, Inc. is a late-stage preclinical biotech company using Artificial Intelligence (AI) to develop small molecule therapeutics for immune-mediated diseases and cancer. Athos...
Regen BioPharma, Inc. announced development of a novel immunotherapy for treatment of solid tumors. Current cellular approaches to kill cancer involve administration of a...
